R. MCCAGUE

1.8k total citations
54 papers, 1.4k citations indexed

About

R. MCCAGUE is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, R. MCCAGUE has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Organic Chemistry and 15 papers in Genetics. Recurrent topics in R. MCCAGUE's work include Estrogen and related hormone effects (15 papers), Enzyme Catalysis and Immobilization (8 papers) and Asymmetric Synthesis and Catalysis (7 papers). R. MCCAGUE is often cited by papers focused on Estrogen and related hormone effects (15 papers), Enzyme Catalysis and Immobilization (8 papers) and Asymmetric Synthesis and Catalysis (7 papers). R. MCCAGUE collaborates with scholars based in United Kingdom, United States and Norway. R. MCCAGUE's co-authors include Gary J. Tarver, Varinder K. Aggarwal, Michael Jarman, Stanley M. Roberts, Andrea Mereu, Susan M. Langan-Fahey, V. Craig Jordan, Grace K. Poon, V. Craig Jordan and Catherine S. Murphy and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

R. MCCAGUE

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. MCCAGUE United Kingdom 20 566 564 537 230 178 54 1.4k
Raymond McCague United Kingdom 26 678 1.2× 625 1.1× 527 1.0× 139 0.6× 269 1.5× 75 1.7k
Gyula Schneider Hungary 26 1.3k 2.3× 956 1.7× 551 1.0× 142 0.6× 125 0.7× 145 1.9k
Erwin von Angerer Germany 29 1.4k 2.5× 713 1.3× 591 1.1× 382 1.7× 64 0.4× 94 2.4k
János Wölfling Hungary 26 1.5k 2.7× 1.1k 1.9× 567 1.1× 161 0.7× 127 0.7× 156 2.2k
M. Vandewalle Belgium 29 1.6k 2.8× 833 1.5× 309 0.6× 186 0.8× 112 0.6× 183 2.8k
Rayomand J. Unwalla United States 19 395 0.7× 428 0.8× 322 0.6× 210 0.9× 72 0.4× 34 1.1k
Nigel Vicker United Kingdom 25 878 1.6× 666 1.2× 405 0.8× 92 0.4× 280 1.6× 48 1.7k
Peter C. Ruenitz United States 17 268 0.5× 254 0.5× 340 0.6× 118 0.5× 143 0.8× 57 811
Bryan H. Norman United States 26 667 1.2× 549 1.0× 166 0.3× 292 1.3× 100 0.6× 49 1.4k
Antonio Mouriño Spain 28 1.2k 2.2× 509 0.9× 419 0.8× 95 0.4× 67 0.4× 143 2.4k

Countries citing papers authored by R. MCCAGUE

Since Specialization
Citations

This map shows the geographic impact of R. MCCAGUE's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. MCCAGUE with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. MCCAGUE more than expected).

Fields of papers citing papers by R. MCCAGUE

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. MCCAGUE. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. MCCAGUE. The network helps show where R. MCCAGUE may publish in the future.

Co-authorship network of co-authors of R. MCCAGUE

This figure shows the co-authorship network connecting the top 25 collaborators of R. MCCAGUE. A scholar is included among the top collaborators of R. MCCAGUE based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. MCCAGUE. R. MCCAGUE is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toogood, Helen S., et al.. (2003). The use of a thermostable signature amidase in the resolution of the bicyclic synthon (rac)-γ-lactam. Tetrahedron. 60(3). 711–716. 46 indexed citations
3.
MCCAGUE, R., et al.. (2000). Asymmetric α-substitution versus aza Diels–Alder reaction of electron deficient N-sulfonyl imines. Journal of the Chemical Society Perkin Transactions 1. 515–525. 15 indexed citations
4.
Gibson, Susan E., et al.. (1999). A Bromoarene Based Approach to Phenylalanine Analogues Hic and Nic. Synlett. 1999(Sup. 1). 954–956. 15 indexed citations
5.
Nuwaysir, Emile F., Yvonne P. Dragan, R. MCCAGUE, et al.. (1998). Structure–Activity Relationships for Triphenylethylene Antiestrogens on Hepatic Phase-I and Phase-II Enzyme Expression. Biochemical Pharmacology. 56(3). 321–327. 7 indexed citations
6.
7.
Adger, Brian M., Sophie Bergeron, Michael W. Cappi, et al.. (1997). Improved procedure for Juliá–Colonna asymmetric epoxidation of α,β-unsaturated ketones: total synthesis of diltiazem and Taxol TM side-chain. Journal of the Chemical Society Perkin Transactions 1. 3501–3508. 112 indexed citations
8.
Aggarwal, Varinder K., Gary J. Tarver, & R. MCCAGUE. (1996). First examples of metal and ligand accelerated catalysis of the Baylis–Hillman reaction. Chemical Communications. 2713–2714. 49 indexed citations
9.
Dragan, Yvonne P., Emile F. Nuwaysir, C A Sattler, et al.. (1996). The effect of tamoxifen and two of its non-isomerizable fixed-ring analogs on multistage rat hepatocarcinogenesis. Carcinogenesis. 17(3). 585–594. 30 indexed citations
10.
Coombes, R. Charles, Benjamin P. Haynes, Mitch Dowsett, et al.. (1995). Idoxifene: report of a phase I study in patients with metastatic breast cancer.. PubMed. 55(5). 1070–4. 54 indexed citations
12.
Osborne, C. Kent, Michael Jarman, R. MCCAGUE, et al.. (1994). The importance of tamoxifen metabolism in tamoxifen-stimulated breast tumor growth. Cancer Chemotherapy and Pharmacology. 34(2). 89–95. 98 indexed citations
14.
Wolf, Danny, Susan M. Langan-Fahey, Christopher Parker, R. MCCAGUE, & V. Craig Jordan. (1993). Investigation of the Mechanism of Tamoxifen-Stimulated Breast Tumor Growth With Nonisomerizable Analogues of Tamoxifen and Metabolites. JNCI Journal of the National Cancer Institute. 85(10). 806–812. 68 indexed citations
15.
Poon, Grace K., Michael Jarman, R. MCCAGUE, et al.. (1992). Identification of 4-hydroxyandrost-4-ene-3,17-dione metabolites in prostatic cancer patients by liquid chromatography—mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 576(2). 235–244. 10 indexed citations
16.
Hoeven, R. A. M. van der, W.M.A. Niessen, U.R. Tjaden, et al.. (1992). On-line continuous-flow dialysis thermospray tandem mass spectrometry for quantitative screening of drugs in plasma: rogletimide. Journal of Chromatography A. 598(2). 189–194. 5 indexed citations
17.
Chander, Surinder K., R. MCCAGUE, Yunus A. Luqmani, et al.. (1991). Pyrrolidino-4-iodotamoxifen and 4-iodotamoxifen, new analogues of the antiestrogen tamoxifen for the treatment of breast cancer.. PubMed. 51(21). 5851–8. 73 indexed citations
18.
MCCAGUE, R., et al.. (1991). Whole cell catalysed kinetic resolution of 6-azabicyclo[3.2.0]hept-3-en-7-one: synthesis of (–)-cispentacin (FR 109615). Journal of the Chemical Society Perkin Transactions 1. 2276–2277. 27 indexed citations
19.
Murphy, Catherine S., Susan M. Langan-Fahey, R. MCCAGUE, & V. Craig Jordan. (1990). Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.. Molecular Pharmacology. 38(5). 737–743. 62 indexed citations
20.
Jarman, Michael & R. MCCAGUE. (1985). Octafluorotoluene as a reagent for the selective protection of alcoholic and phenolic functions: Synthesis and cleavage of perfluorotolyl and other perfluoroaryl ethers of steroids and other model compounds.. Journal of Chemical Research Synopses. 114–115. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026